Article
Predicting the clinical outcome of melanoma using an immune-related gene pairs signature.
PloS one - 1 Jan 2020
Meng Liangliang, He Xiaoxi, Zhang Xiao, Zhang Xiaobo, Wei Yingtian, Wu Bin, Li Wei, Li Jing, Xiao Yueyong
Abstract excerpt
OBJECTIVE: Melanoma is rare but dangerous skin cancer, and it can spread rather quickly in the advanced stages of the tumor. Abundant evidence suggests the relationship between tumor development and progression and the immune system. A robust gene risk model could provide an accurate prediction of clinical outcomes. The present study aimed to explore a robust signature of immune-related gene pairs (IRGPs) for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
